UK markets closed

Sesen Bio, Inc. (SESN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.9295+0.0852 (+10.09%)
As of 12:03PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
22,234
26,544
11,236
0
0
Operating expenses
Research development
23,994
25,312
29,191
24,663
14,077
Selling general and administrative
33,075
29,393
14,302
12,208
11,623
Total operating expenses
57,069
54,705
43,493
36,871
25,700
Operating income or loss
-34,835
-28,161
-32,257
-36,871
-25,700
Interest expense
-
-
-
-
0
Total other income/expenses net
80,643
19,552
11,305
-70,629
-7,993
Income before tax
45,808
-8,609
-20,952
-107,500
-33,693
Income tax expense
-8,561
-8,273
1,445
-
0
Income from continuing operations
54,369
-336
-22,397
-107,500
-33,693
Net income
54,369
-336
-22,397
-107,500
-33,693
Net income available to common shareholders
54,369
-336
-22,544
-107,500
-33,693
Basic EPS
-
-0.00
-0.19
-1.18
-0.55
Diluted EPS
-
-0.00
-0.19
-1.18
-0.55
Basic average shares
-
182,323
118,221
90,929
61,774
Diluted average shares
-
182,323
118,221
90,929
61,774
EBITDA
-
-28,076
-32,135
-36,652
-33,485